ObsEva SA Logo

ObsEva SA

ISIN

CH0346177709

Ticker

OBSN

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

Switzerland

Year Founded

2012

About ObsEva SA

Company Description

Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

Served Area

Worldwide

Headquarters

Chemin des Aulx 12
1228, Plan-les-Ouates
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.03.2022 None Non-Executive member Buy CHF 2,058.00
16.03.2022 None Non-Executive member Buy CHF 27,010.00
15.03.2022 None Non-Executive member Buy CHF 23,642.00
08.02.2022 None Non-Executive member Buy CHF 64,161.00
01.02.2022 None Non-Executive member Buy CHF 70,716.00
24.01.2022 None Non-Executive member Buy CHF 69,748.00
11.01.2022 None Non-Executive member Buy CHF 183,535.00
10.01.2022 None Non-Executive member Buy CHF 177,643.00

Capital Markets Information

ISIN

CH0346177709

LEI

549300PNZ0UEJVKN1618

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.